{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:49:20Z","timestamp":1793137760762,"version":"4.5.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,15]]},"abstract":"<jats:p>The potential value of epigenetic DNA methylation in early cancer screening has been demonstrated. Therefore, in this study, we performed QMS-PCR and quantitative reverse transcription PCR on the genes <jats:italic toggle=\"yes\">RASSF1A, H4C6, SEPT9, GSTP1, PAX1, SHOX2<\/jats:italic>, and <jats:italic toggle=\"yes\">SOX2<\/jats:italic>, which are common in epithelial cancers. We found hypermethylation in <jats:italic toggle=\"yes\">RASSF1A, H4C6<\/jats:italic> and <jats:italic toggle=\"yes\">SEPT9<\/jats:italic>. The mRNA expressions of <jats:italic toggle=\"yes\">RASSF1A, H4C6<\/jats:italic> and <jats:italic toggle=\"yes\">SEPT9<\/jats:italic> in tumor group were significantly different from those in the inflammatory group and healthy group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). Receiver operating characteristic (ROC) analysis showed that the area under the curve (AUC) of <jats:italic toggle=\"yes\">RASSF1A, H4C6<\/jats:italic> and <jats:italic toggle=\"yes\">SEPT9<\/jats:italic> genes were 0.831, 0.856 and 0.767, respectively. The areas under the AUC curve of <jats:italic toggle=\"yes\">SEPT9\u2005+\u2005H4C6, SEPT9\u2005+\u2005RASSF1A<\/jats:italic> and <jats:italic toggle=\"yes\">H4C6\u2005+\u2005RASSF1A<\/jats:italic> are 0.946, 0.912 and 0.851, respectively. The diagnostic ability of dual gene combination is better than that of single gene combination, among which <jats:italic toggle=\"yes\">SEPT9<\/jats:italic> and <jats:italic toggle=\"yes\">H4C6<\/jats:italic> combination has the best diagnostic effect. In conclusion, our findings suggest that <jats:italic toggle=\"yes\">H4C6, RASSF1A<\/jats:italic>, and <jats:italic toggle=\"yes\">SEPT9<\/jats:italic> methylation occur more frequently in nasopharyngeal carcinoma, and their detection in nasopharyngeal swabs may be a minimally invasive tool for diagnosis of nasopharyngeal carcinoma.<\/jats:p>","DOI":"10.1097\/md.0000000000036583","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T21:10:07Z","timestamp":1702674607000},"page":"e36583","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["SEPT9, H4C6, and RASSF1A methylation in nasopharyngeal swabs: A reflection of potential minimally invasive biomarkers for early screening of nasopharyngeal cancer"],"prefix":"10.1097","volume":"102","author":[{"given":"Tai","family":"Qian","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9853-3583","authenticated-orcid":false,"given":"Zhiwei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongxia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Light","family":"Liou","sequence":"additional","affiliation":[{"name":"Clinical Precision Medicine Research Center, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Clinical Precision Medicine Research Center, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma.","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4143\/crt.2008.40.4.155","article-title":"Radiation therapy combined with (or without) cisplatin-based chemotherapy for patients with nasopharyngeal cancer: 15-years experience of a single institution in Korea.","volume":"40","author":"Kim","year":"2008","journal-title":"Cancer Res Treat"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/annonc\/mdz231","article-title":"Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.","volume":"30","author":"Ji","year":"2019","journal-title":"Ann Oncol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma Epstein-Barr Virus DNA to screen for nasopharyngeal cancer.","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med"},{"key":"R6-20250504","first-page":"23","article-title":"Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma.","volume":"12","author":"Chen","year":"2015","journal-title":"Cancer Biol Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/eci.12406","article-title":"Biological embedding of early-life exposures and disease risk in humans: a role for DNA methylation.","volume":"45","author":"Demetriou","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/epi.09.47","article-title":"Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women\u2019s cancers.","volume":"2","author":"Jones","year":"2010","journal-title":"Epigenomics"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1021\/tx900099s","article-title":"DNA methylation at the C-5 position of cytosine by methyl radicals: a possible role for epigenetic change during carcinogenesis by environmental agents.","volume":"22","author":"Kasai","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.ctdb.2022.06.002","article-title":"Cancer and meiotic gene expression: two sides of the same coin?","volume":"151","author":"Sou","year":"2023","journal-title":"Curr Top Dev Biol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s10620-017-4740-6","article-title":"Bioinformatics-based identification of methylated-differentially expressed genes and related pathways in gastric cancer.","volume":"62","author":"Li","year":"2017","journal-title":"Dig Dis Sci"},{"key":"R12-20250504","first-page":"8","article-title":"Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research.","volume":"38","author":"Zhang","year":"2018","journal-title":"Cancer Commun (Lond)"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2353\/jmoldx.2006.050135","article-title":"Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.","volume":"8","author":"Ogino","year":"2006","journal-title":"J Mol Diagn"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/IGC.0b013e3181c7fe6e","article-title":"Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.","volume":"20","author":"Huang","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.23519","article-title":"Identification of novel DNA methylation markers in cervical cancer.","volume":"123","author":"Lai","year":"2008","journal-title":"Int J Cancer"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13148-015-0084-2","article-title":"Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results.","volume":"7","author":"Liou","year":"2015","journal-title":"Clin Epigenetics"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/17246008211065472","article-title":"Hypermethylation of the RASSF1A gene promoter as the tumor DNA marker for nasopharyngeal carcinoma.","volume":"37","author":"Lao","year":"2022","journal-title":"Int J Biol Markers"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ijc.31539","article-title":"Cervical cancer risk in HPV-positive women after a negative FAM19A4\/mir124-2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up.","volume":"143","author":"De Strooper","year":"2018","journal-title":"Int J Cancer"},{"key":"R19-20250504","first-page":"5021","article-title":"Fields of aberrant CpG island hypermethylation in Barrett\u2019s esophagus and associated adenocarcinoma.","volume":"60","author":"Eads","year":"2000","journal-title":"Cancer Res"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1158\/1078-0432.CCR-03-0622","article-title":"Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study.","volume":"10","author":"Sun","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1158\/1078-0432.CCR-09-0580","article-title":"Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.","volume":"15","author":"Cao","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:13:50Z","timestamp":1746321230000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":21,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036583","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}